1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The global antifungal skin therapeutics market is at a critical juncture, shaped by evolving scientific advances, mounting regulatory complexity, and shifting patient expectations. Decision-makers are navigating innovation in drug classes, growing demand for targeted therapies, and heightened supply chain considerations, all influencing current and future market strategies.
Market Snapshot: Antifungal Skin Therapeutics Market
The market for antifungal skin drugs demonstrates robust growth amid a landscape defined by surging innovation and unmet medical needs. Innovation in both established and novel therapeutic classes propels treatment evolution for dermatophyte infections, while manufacturers face increasing pressure to balance efficacy, safety, and affordability. Clinicians and manufacturers are responding to greater regulatory oversight and expanded patient populations, signaling ongoing transformation driven by product innovation, digital engagement, and regulatory changes.
Scope & Segmentation
- Drug Classes: Allylamines, imidazoles, triazoles, polyenes
- Dosage Forms: Creams, gels, ointments, powders, sprays
- Product Types: Over the counter offerings, prescription medications
- Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
- Indications: Tinea corporis, tinea cruris, tinea pedis
- Routes of Administration: Oral, topical
- Key Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
- Key Companies: Novartis AG, Bayer AG, Johnson & Johnson, GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc.
Key Takeaways for Senior Decision-Makers
- Pipeline innovation is centered around next-generation triazoles and advanced molecular scaffolds to combat resistant fungal pathogens.
- Patient-centered solutions are accelerating, with digital adherence tools, remote symptom tracking, and the expansion of e-pharmacy models playing pivotal roles in engagement and retention.
- Regulatory fragmentation across regions requires adaptive go-to-market and licensing strategies, particularly in the Middle East, Africa, and across Asia-Pacific jurisdictions.
- Strategic alliances, including partnerships with contract manufacturers and local distributors, are strengthening market access and mitigating risks linked to supply chain disruption.
- Real-world evidence and robust pharmacoeconomic assessments are increasingly necessary for securing favorable formulary placement and payer acceptance.
- Emerging technology and personalized medicine approaches, such as microbiome profiling and genetic marker analysis, are influencing both product development and clinical positioning.
Impact of New 2025 Trade Tariffs on Market Dynamics
Newly introduced tariffs in 2025 on select pharmaceutical ingredients are driving up input costs for antifungal drug manufacturers, especially those relying on imported excipients and active pharmaceutical ingredients. As a result, companies are renegotiating supplier relationships and exploring alternate sourcing from regions with favorable trade terms. These tariffs have prompted contract manufacturers and brand developers to reassess pricing, adapt supply strategies, and deepen dialogue on improving supply chain resilience. Health systems are more closely reviewing product value, emphasizing cost containment, and favoring therapies with established rebate structures.
Methodology & Data Sources
This report integrates in-depth qualitative interviews with dermatologists, pharmaceutical scientists, and supply chain executives. Secondary analysis covers peer-reviewed scientific literature, patent databases, regulatory agency filings, and comprehensive trade data. Quantitative insights are validated via data triangulation using multiple sources; accuracy is maintained through expert panel reviews and rigorous verification protocols.
Why This Report Matters
- Enables informed strategic planning by clarifying innovation trends, geographic opportunities, and evolving regulatory influences in the antifungal skin therapeutics market.
- Delivers practical intelligence on product segmentation, supply chain adaptation, and effective stakeholder engagement—critical for portfolio optimization and market entry.
- Supports assessment of partnership models, digital engagement strategies, and evidence generation for market leadership and sustainable growth.
Conclusion
The antifungal skin therapeutics market is driven by science, technology, and rapidly evolving competitive strategies. Leaders who integrate data-driven innovation and operational agility will secure market advantage as the landscape continues to shift in complexity and opportunity.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of nanoencapsulation technology enabling sustained antifungal delivery to skin lesions
5.2. Growing adoption of combination therapy creams to address resistant dermatophyte infections in immunocompromised patients
5.3. Integration of digital adherence monitoring devices to collect real-world efficacy data on topical antifungal regimens
5.4. Rising investment in repurposing systemic antifungal compounds for optimized topical skin formulations
5.5. Surge in over-the-counter availability of broad-spectrum azole antifungals driven by streamlined regulatory approvals
5.6. Increasing market demand for natural ingredient-based antifungal creams with validated antimicrobial activity
5.7. Development of novel antifungal peptides targeting biofilm formation in chronic cutaneous candidiasis treatment
5.2. Growing adoption of combination therapy creams to address resistant dermatophyte infections in immunocompromised patients
5.3. Integration of digital adherence monitoring devices to collect real-world efficacy data on topical antifungal regimens
5.4. Rising investment in repurposing systemic antifungal compounds for optimized topical skin formulations
5.5. Surge in over-the-counter availability of broad-spectrum azole antifungals driven by streamlined regulatory approvals
5.6. Increasing market demand for natural ingredient-based antifungal creams with validated antimicrobial activity
5.7. Development of novel antifungal peptides targeting biofilm formation in chronic cutaneous candidiasis treatment
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Antifungal Drugs for Skin Market, by Drug Class
8.1. Introduction
8.2. Allylamines
8.3. Azoles
8.3.1. Imidazoles
8.3.2. Triazoles
8.4. Polyenes
8.2. Allylamines
8.3. Azoles
8.3.1. Imidazoles
8.3.2. Triazoles
8.4. Polyenes
9. Antifungal Drugs for Skin Market, by Dosage Form
9.1. Introduction
9.2. Cream
9.3. Gel
9.4. Ointment
9.5. Powder
9.6. Spray
9.2. Cream
9.3. Gel
9.4. Ointment
9.5. Powder
9.6. Spray
10. Antifungal Drugs for Skin Market, by Product Type
10.1. Introduction
10.2. Over The Counter
10.3. Prescription
10.2. Over The Counter
10.3. Prescription
11. Antifungal Drugs for Skin Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Antifungal Drugs for Skin Market, by Indication
12.1. Introduction
12.2. Tinea Corporis
12.3. Tinea Cruris
12.4. Tinea Pedis
12.2. Tinea Corporis
12.3. Tinea Cruris
12.4. Tinea Pedis
13. Antifungal Drugs for Skin Market, by Route Of Administration
13.1. Introduction
13.2. Oral
13.3. Topical
13.2. Oral
13.3. Topical
14. Americas Antifungal Drugs for Skin Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Antifungal Drugs for Skin Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Antifungal Drugs for Skin Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Novartis AG
17.3.2. Bayer AG
17.3.3. Johnson & Johnson
17.3.4. GlaxoSmithKline plc
17.3.5. Pfizer Inc.
17.3.6. Sanofi S.A.
17.3.7. Bausch Health Companies Inc.
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Sandoz International GmbH
17.3.10. Viatris Inc.
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Novartis AG
17.3.2. Bayer AG
17.3.3. Johnson & Johnson
17.3.4. GlaxoSmithKline plc
17.3.5. Pfizer Inc.
17.3.6. Sanofi S.A.
17.3.7. Bausch Health Companies Inc.
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Sandoz International GmbH
17.3.10. Viatris Inc.
List of Figures
FIGURE 1. ANTIFUNGAL DRUGS FOR SKIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANTIFUNGAL DRUGS FOR SKIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANTIFUNGAL DRUGS FOR SKIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ANTIFUNGAL DRUGS FOR SKIN MARKET: RESEARCHAI
FIGURE 28. ANTIFUNGAL DRUGS FOR SKIN MARKET: RESEARCHSTATISTICS
FIGURE 29. ANTIFUNGAL DRUGS FOR SKIN MARKET: RESEARCHCONTACTS
FIGURE 30. ANTIFUNGAL DRUGS FOR SKIN MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANTIFUNGAL DRUGS FOR SKIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANTIFUNGAL DRUGS FOR SKIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ANTIFUNGAL DRUGS FOR SKIN MARKET: RESEARCHAI
FIGURE 28. ANTIFUNGAL DRUGS FOR SKIN MARKET: RESEARCHSTATISTICS
FIGURE 29. ANTIFUNGAL DRUGS FOR SKIN MARKET: RESEARCHCONTACTS
FIGURE 30. ANTIFUNGAL DRUGS FOR SKIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIFUNGAL DRUGS FOR SKIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ALLYLAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY IMIDAZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY IMIDAZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TRIAZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TRIAZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY POLYENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY POLYENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA CORPORIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA CORPORIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA CRURIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA CRURIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA PEDIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA PEDIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 224. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 225. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 226. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 227. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 228. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 229. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 296. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 297. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 298. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 299. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 304. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 305. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MAR
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ALLYLAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY IMIDAZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY IMIDAZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TRIAZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TRIAZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY POLYENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY POLYENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA CORPORIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA CORPORIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA CRURIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA CRURIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA PEDIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TINEA PEDIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. GERMANY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. FRANCE ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 224. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 225. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 226. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 227. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 228. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 229. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. ITALY ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. SPAIN ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 296. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 297. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 298. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 299. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 304. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 305. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. DENMARK ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS ANTIFUNGAL DRUGS FOR SKIN MAR
Samples
LOADING...
Companies Mentioned
The companies profiled in this Antifungal Drugs for Skin Market report include:- Novartis AG
- Bayer AG
- Johnson & Johnson
- GlaxoSmithKline plc
- Pfizer Inc.
- Sanofi S.A.
- Bausch Health Companies Inc.
- Teva Pharmaceutical Industries Ltd.
- Sandoz International GmbH
- Viatris Inc.
